lunes, 3 de marzo de 2014

Clinical Pharmacogenetics Implementation... [Clin Pharmacol Ther. 2014] - PubMed - NCBI

Clinical Pharmacogenetics Implementation... [Clin Pharmacol Ther. 2014] - PubMed - NCBI



 2014 Feb 21. doi: 10.1038/clpt.2014.38. [Epub ahead of print]

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update.

Abstract

The Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B Genotype and Abacavir Dosing was originally published in April 2012. We reviewed recent literature and concluded that none of the evidence would change the therapeutic recommendations in the original guideline; therefore, the original publication remains clinically current. However, we have updated the supplemental material and included additional resources for applying CPIC guidelines into the electronic health record. Up-to-date information can be found at PharmGKB (http://www.pharmgkb.org).Clinical Pharmacology & Therapeutics (2014); Accepted article preview online 21 February 2014. doi:10.1038/clpt.2014.38.

PMID:
 
24561393
 
[PubMed - as supplied by publisher]

No hay comentarios:

Publicar un comentario